Report Materials
EXECUTIVE SUMMARY:
The objective of this review was to determine whether transitional pass-through payments for drugs, biologicals, and medical devices were reimbursed in accordance with Medicare laws and regulations. Based on our review of payments to the hospital for 100 sample pass-through items, we determined that the hospital was reimbursed for pass-through drugs, biologicals, and medical devices in accordance with Medicare laws and regulations. In this respect, we found that all sample items were eligible for transitional pass-through payments and were billed properly by the hospital.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.